| Literature DB >> 28475139 |
Anna Fagre1, Francisco Olea-Popelka2, Rebecca Ruch-Gallie3.
Abstract
The purpose of this study was to describe intake procedures in Colorado animal shelters, compare infectious disease screening protocols in shelters taking in animals from out-of-state to shelters only accepting animals from Colorado, and analyze perceived risk of diseases in Colorado by responding shelter personnel. A questionnaire was designed and administered to shelter personnel across the state of Colorado via the survey tool SurveyMonkey© (http://www.surveymonkey.com) or a mailed hard copy. Information collected concerned general shelter characteristics and intake procedures performed in various circumstances as reported by responding shelter personnel. Only 12.5% (5/40) of respondents reported providing core vaccines to all animals upon intake at their shelter, with young age (65.0%; 26/40), pregnancy (55.0%; 22/40), and mild existing illness (40.0%; 16/40) being cited as the top reasons for not administering core vaccines. A significantly larger proportion of shelters taking animals in from around the U.S. screened for Dirofilaria immitis than shelters taking in animals only from within the state of Colorado (p = 0.001), though a majority of respondents considered cats and dogs to be at risk of heartworm and endoparasitic infection in the state of Colorado. Based on the results of this questionnaire, relatively few shelters test dogs and cats for infectious diseases and some of those utilize tests for diagnostic purposes rather than routine screening. Additionally, vaccination protocols in several shelters are not consistent with The Association of Shelter Veterinarians Guidelines for Standards of Care in Animal Shelters. This study provides important information on intake procedures in Colorado animal shelters and highlights the importance of educating shelter staff on varying risk of infection based on the history and origin of the animal being taken in.Entities:
Keywords: Dirofilaria immitis; animal shelters; gastrointestinal endoparasites; infectious disease; intake procedures; natural disasters; transfer
Year: 2017 PMID: 28475139 PMCID: PMC5447920 DOI: 10.3390/ani7050038
Source DB: PubMed Journal: Animals (Basel) ISSN: 2076-2615 Impact factor: 2.752
Figure 1Respondents were asked which diseases they vaccinate dogs for upon intake at their shelter (n = 32). An asterisk (*) was used to denote diseases immunized using either a monovalent or multivalent vaccine.
Figure 2Respondents were asked which diseases they vaccinate cats against upon intake at their shelter (n = 29). An asterisk (*) was used to denote diseases immunized using either a monovalent or multivalent vaccine.
Proportion of responding shelters that screen for various infectious diseases in dogs and cats, categorized on the basis of whether or not they accept intakes from out-of-state.
|
| Disease Screening | Total | Colorado Only Intakes | Nationwide Intakes | ||
|---|---|---|---|---|---|---|
| Canine | 44 | Any disease screening | 50% (22/44) | 33.3% (7/21) | 65% (15/23) | 0.069 |
| 43 | Heartworm | 37.2% (16/43) | 10% (2/20) | 69% (14/23) | 0.0012 | |
| 42 | Ehrlichia | 4.8% (2/42) | 0% (0/21) | 9.5% (2/21) | 0.488 | |
| 43 | Lyme | 7% (3/43) | 0% (0/21) | 13.6% (3/22) | 0.233 | |
| 42 | Anaplasma | 0% (0/42) | 0% (0/21) | 0% (0/21) | 1 | |
| 43 | Giardia | 18.6% (8/43) | 4.8% (1/21) | 31.8% (7/22) | 0.046 | |
| 43 | Hookworm | 16.3% (7/43) | 0% (0/21) | 31.8% (7/22) | 0.046 | |
| 43 | Roundworm | 18.6% (8/43) | 0% (0/21) | 36.4% (8/22) | 0.004 | |
| 43 | Whipworm | 16.3% (7/43) | 0% (0/21) | 31.8% (7/22) | 0.009 | |
| 43 | Tapeworm | 18.6% (8/43) | 4.8% (1/21) | 31.8% (7/22) | 0.046 | |
| 43 | Coccidia | 9.3% (4/43) | 0% (0/21) | 18.2% (4/22) | 0.108 | |
| 43 | Flukes | 2.3% (1/43) | 0% (0/21) | 4.5% (1/22) | 1 | |
| 43 | Trichomoniasis | 2.3% (1/43) | 0% (0/21) | 4.5% (1/22) | 1 | |
| 43 | Cryptosporidium | 2.3% (1/43) | 0% (0/21) | 4.5% (1/22) | 1 | |
| 43 | Ringworm | 25.6% (11/43) | 14.3% (3/21) | 36.4% (8/22) | 0.162 | |
| Feline | 41 | Any disease screening | 43.9% (18/41) | 33.3% (6/18) | 52.2% (12/23) | 0.343 |
| 33 | FelV | 48.5% (16/33) | 33.3% (5/15) | 61.1% (11/18) | 0.166 | |
| 32 | FIV | 43.8% (14/32) | 33.3% (5/15) | 52.9% (9/17) | 0.308 | |
| 33 | Heartworm | 6.1% (2/33) | 0% (0/15) | 11.1% (2/18) | 0.489 | |
| 21 | Giardia | 4.8% (1/21) | 0% (0/11) | 10% (1/10) | 0.476 | |
| 32 | Hookworm | 9.4% (3/32) | 0% (0/15) | 17.6% (3/17) | 0.229 | |
| 22 | Roundworm | 13.6% (3/22) | 0% (0/11) | 27.3% (3/11) | 0.489 | |
| 28 | Whipworm | 10.7% (3/28) | 0% (0/13) | 20% (3/15) | 0.226 | |
| 21 | Tapeworm | 14.3% (3/21) | 0% (0/11) | 33.3% (3/10) | 0.090 | |
| 29 | Trichomoniasis | 6.9% (2/29) | 0% (0/14) | 13.3% (2/15) | 0.483 | |
| 20 | Coccidia | 10% (2/20) | 0% (0/11) | 22.2% (2/9) | 0.190 | |
| 28 | Flukes | 0% (0/28) | 0% (0/14) | 0% (0/14) | 1 | |
| 19 | Cryptosporidium | 0% (0/19) | 0% (0/11) | 0% (0/8) | 1 | |
| 30 | Ringworm | 40% (12/30) | 26.7% (4/15) | 53% (8/15) | 0.264 |
Proportion of respondents indicating which screening method(s) are used in their shelter for various canine diseases.
| Disease | Screening Methods | Disease | Screening Methods |
|---|---|---|---|
| Serologic antigen test (100%, 17/17) | Fecal flotation (100%, 7/7) | ||
| Detection of antibodies by IFA (50%, 1/2) | Fecal flotation (75%, 6/8) | ||
| Serologic antibody test (100%, 3/3) | Signalment, clinical signs, history, and structure of oocysts present in feces (66.7%, 4/6) | ||
| N/A | Fecal sedimentation (100%, 2/2) | ||
| Fecal flotation (37.5%, 3/8) | Direct fecal smear (100%, 1/1) | ||
| Fecal flotation (85.7%, 6/7) | ELISA assay (100%, 1/1) | ||
| Fecal flotation (100%, 8/8) | Clinical signs (e.g. alopecia, pruritis, erythema, crusting of skin) (90.9% (10/11)) |
Proportion of respondents indicating which screening method(s) are used in their shelter for various feline diseases.
| Disease | Screening Methods | Disease | Screening Methods |
|---|---|---|---|
| Heartworm serology test (100%, 2/2) | Fecal flotation (100%, 3/3) | ||
| Antigen serology test (100%, 15/15) | Identification of proglottids in feces/vomit (37.5%, 9/24) | ||
| Antibody serology test (100%, 15/15) | Fecal flotation (32%, 8/25) | ||
| Fecal flotation (32.1%, 9/28) | N/A | ||
| Fecal flotation (100%, 4/4) | Direct fecal smear (66.7%, 2/3) | ||
| Fecal flotation (37.5%, 9/24) | ELISA assay (2.5%, 2/19) | ||
| Clinical signs (e.g. alopecia, pruritis, erythema, crusting of skin) (55.3% (16/30)) | |||
Actions taken upon diagnosis and associated treatment protocols.
| Disease | Actions Taken | Treatment |
|---|---|---|
| Treat and adopt out (93.75%, 15/16) | Melarsomine dihydrochloride (76.92%, 10/13) | |
| Treat and adopt out (93.75%, 15/16) | Melarsomine dihydrochloride (76.92%, 10/13) | |
| Treat and adopt out (90%, 18/20) | Pyrantel (75%, 12/16) | |
| Treat and adopt out (60.6%, 20/33) | Pyrantel (54.6%, 12/22) |
Respondents indicating “yes” or “uncertain” to a perceived risk were included as positive risk perception.
| n | Perceived Risk | CO Only Intakes | Nationwide Intakes | p-Value |
|---|---|---|---|---|
| 39 | HW risk in dogs | 64.7% (11/17) | 86.4% (19/22) | 0.142 |
| 38 | HW risk in cats | 58.8% (10/17) | 61.9% (13/21) | 1 |
| 37 | Endoparasitic: dogs | 94.1% (16/17) | 90% (18/20) | 1 |
| 36 | Endoparasitic: cats | 87.5% (14/16) | 90% (18/20) | 1 |